The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Open accessAbstract
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer. Whole-genome sequencing of tumours from 560 breast cancer cases provides a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions; several mutational signatures in these cancer genomes are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. This study reports whole-genome sequencing of tumours and normal tissue from 560 breast cancer cases, providing a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions. The authors analyse mutational signatures in these cancer genomes, including a new investigation of rearrangement mutational processes, and find several that are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. They also find mutational signatures showing distinct DNA replication strand biases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, BRCA inactivation is known to promote genomic instability through homologous recombination deficiencies in several solid tumors such as breast and ovarian cancer.47”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, some mutational footprints were found to be associated with BRCA1/2 deficiency, namely deletions with flanking microhomology, as well as several “mutational signatures” including two COSMIC single nucleotide variant (SNV) signatures and two structural variant (SV) signatures8.”
From Pan-cancer landscape of homologous recombination deficiency. (2020) · cites this paper as [8]
In the citing paper
“These genomic features in the SCAN-B TNBC cohort were comparable to a previously reported WGS cohort8”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [8]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Seventy-nine out of the 93 previously identified BC driver genes [9] were mutated”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Despite the role of TP53, ATM and CHEK2 in DNA-damage signalling and double-strand breaks detection, these tumours do not show evidence of BRCA-deficient signatures, as previously described [9, 13, 19], but instead they harbour highly complex clustered chromosomal rearrangements.”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“The variant was not reported in gnomAD or in the 560 BC genomes cohort [9] and is described by ClinVar (Variation ID: 135816) as ‘Class 3 Uncertain significance’”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Loss of function of BRCA1, BRCA2 and PALB2 yield a high mutation burden and specific signatures inferring defective HR [7, 9, 10, 13].”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“These clustered events coincided with amplifications of known BC oncogenes (e.g. ZNF217, ERBB2, CCND1, MYC) [9]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationVelvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Self-citationThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cited by
Sorted by citations
Items 301–400 of 1,002
The Unfolded Protein Response in Breast Cancer
McGrath, E. P., Logue, S., Mnich, K., Deegan, S., Jäger, R., Gorman, A. M., & Samali, A. (2018) · Cancers · doi:10.3390/cancers10100344 · Cited by 84
Unscrambling cancer genomes via integrated analysis of structural variation and copy number
Shale, C., Cameron, D., Baber, J., Wong, M., Cowley, M. J., Papenfuss, A. T., Cuppen, E. P. J. G., & Priestley, P. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100112 · Cited by 83
Homologous Recombination Deficiency in Breast Cancer: A Clinical Review
den Brok, W. D., Schrader, K. A., Sun, S. B., Tinker, A. V., Stutheit-Zhao, E. Y., Aparicio, S. A. J. R., & Gelmon, K. A. (2017) · JCO Precision Oncology · doi:10.1200/po.16.00031 · Cited by 86
Shinde, J., Bayard, Q., Imbeaud, S., Hirsch, T. Z., Liu, F., Renault, V., Zucman‐Rossi, J., & Letouzé, É. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty388 · Cited by 86
D’Antonio, M., Benaglio, P., Jakubosky, D. A., Greenwald, W. W. Y., Matsui, H., Donovan, M. K. R., Li, H., Smith, E. N., D’Antonio‐Chronowska, A., & Frazer, K. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.091 · Cited by 90
Patterns of Genomic Instability in Breast Cancer
Kalimutho, M., Nones, K., Srihari, S., Duijf, P. H. G., Waddell, N., & Khanna, K. K. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.005 · Cited by 87
Xing, R., Zhou, Y., Yu, J., Yu, Y., Nie, Y., Luo, W., Yang, C., Xiong, T., Wu, W. K. K., Li, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09644-6 · Cited by 85
Khabirova, E., Jardine, L., Coorens, T. H. H., Webb, S., Treger, T. D., Engelbert, J., Porter, T., Prigmore, E., Collord, G., Piapi, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01720-7 · Cited by 89
Krings, G., Joseph, N. M., Bean, G. R., Solomon, D. A., Onodera, C. S., Talevich, E., Yeh, I., Grenert, J. P., Hosfield, E. M., Crawford, E. D., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.32 · Cited by 88
RHO GTPases in cancer: known facts, open questions, and therapeutic challenges
Bustelo, X. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170531 · Cited by 89
Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
Seyfried, T. N., Yu, G. W., Maroon, J. C., & D’Agostino, D. P. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0178-2 · Cited by 86
Translating insights into tumor evolution to clinical practice: promises and challenges
Fittall, M. W., & Loo, P. V. (2019) · Genome Medicine · doi:10.1186/s13073-019-0632-z · Cited by 91
Modeling Therapy Resistance in BRCA1/2 -Mutant Cancers
Dréan, A., Williamson, C. T., Brough, R., Brandsma, I., Menon, M. R., Konde, A., García-Murillas, I., Pemberton, H. N., Frankum, J. R., Rafiq, R., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0098 · Cited by 84
Whole-Genome Sequencing in CancerPreprint
Stutheit-Zhao, E. Y., Jones, M. R., & Jones, S. J. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034579 · Cited by 93
Triple-negative breast cancers — a panoply of cancer types
Pareja, F. G., & Reis-Filho, J. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0001-7 · Cited by 86
Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
Taylor, J., & Lee, S. C.-W. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22784 · Cited by 88
Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
Custers, L., Khabirova, E., Coorens, T. H. H., Oliver, T. R. W., Calandrini, C., Young, M. D., Braga, F. A. V., Ellis, P., Mamanova, L., Segers, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21675-6 · Cited by 84
When Genome Maintenance Goes Badly Awry
Kass, E. M., Moynahan, M. E., & Jasin, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.021 · Cited by 84
Wu, S., Ou, T., Xing, N., Jiang, L., Wan, S., Wang, C., Zhang, X., Yang, F., Huang, Y. F., & Cai, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-08576-5 · Cited by 87
New Advances in Molecular Breast Cancer Pathology
Rakha, E. A., & Pareja, F. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.014 · Cited by 85
Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
Foo, T. K., Tischkowitz, M. D., Simhadri, S. R., Boshari, T., Zayed, N., Burke, K. A., Berman, S. H., Blecua, P., Riaz, N., Huo, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.46 · Cited by 86
NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?
Weren, R. D. A., Ligtenberg, M. J. L., van Kessel, A. G., de Voer, R. M., Hoogerbrugge, N., & Kuiper, R. P. (2017) · The Journal of Pathology · doi:10.1002/path.5002 · Cited by 86
Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
Ratnaparkhe, M., Wong, J., Wei, P., Hlevnjak, M., Kolb, T., Simovic-Lorenz, M., Haag, D., Paul, Y., Devens, F., Northcott, P. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06925-4 · Cited by 84
Self-citationTherapeutic and prognostic insights from the analysis of cancer mutational signatures
Brady, S. W., Gout, A. M., & Zhang, J. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.08.007 · Cited by 82
The evolutionary theory of cancer: challenges and potential solutions
Laplane, L., & Maley, C. C. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00734-2 · Cited by 89
Scales and mechanisms of somatic mutation rate variation across the human genome
Supek, F., & Lehner, B. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102647 · Cited by 76
Regulation and pharmacological targeting of RAD51 in cancer
Grundy, M. K., Buckanovich, R. J., & Bernstein, K. A. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa024 · Cited by 85
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
Webster, A., Sanders, M. A., Patel, K., Dietrich, R., Noonan, R. J., Lach, F. P., White, R. R., Goldfarb, A. M., Hadi, K., Edwards, M. M., et al. (2022) · Nature · doi:10.1038/s41586-022-05253-4 · Cited by 96
Self-citationLi, J., Xiao, Z., Wang, D., Jia, L., Nie, S., Zeng, X., & Hu, W. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01844-5 · Cited by 95
Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases
Schrijver, W. A. M. E., Selenica, P., Lee, J. Y., Ng, C. K. Y., Burke, K. A., Piscuoglio, S., Berman, S., Reis-Filho, J. S., Weigelt, B., van Diest, P. J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2310 · Cited by 82
Self-citationGlobal Inequities in Precision Medicine and Molecular Cancer Research
Drake, T. M., Knight, S. R., Harrison, E. M., & Søreide, K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00346 · Cited by 83
Tumor diversity and the trade-off between universal cancer tasks
Hausser, J., Székely, P., Bar, N., Zimmer, A., Sheftel, H., Caldas, C., & Alon, U. (2019) · Nature Communications · doi:10.1038/s41467-019-13195-1 · Cited by 78
Self-citationCOTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells
Synnott, N. C., O’Connell, D. J., Crown, J. P., & Duffy, M. J. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05435-1 · Cited by 82
Targeting DNA Damage Response in Prostate and Breast Cancer
Wengner, A. M., Scholz, A., & Haendler, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218273 · Cited by 81
Westphalen, C. B., Fine, A. D., André, F., Ganesan, S., Heinemann, V., Rouleau, É., Turnbull, C., Palacios, L. G., López, J. A., Sokol, E. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2096 · Cited by 78
Fujimoto, A., Fujita, M., Hasegawa, T., Wong, J. H., Maejima, K., Oku‐Sasaki, A., Nakano, K., Shiraishi, Y., Miyano, S., Imoto, S., et al. (2020) · Genome Research · doi:10.1101/gr.255026.119 · Cited by 79
Self-citationDetailed modeling of positive selection improves detection of cancer driver genes
Zhao, S., Liu, J., Nanga, P., Liu, Y., Çiçek, A. E., Knoblauch, N., He, C., Stephens, M., & He, X. (2019) · Nature Communications · doi:10.1038/s41467-019-11284-9 · Cited by 77
Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA
Morimoto, S., Tsuda, M., Bunch, H., Sasanuma, H., Austin, C. A., & Takeda, S. (2019) · Genes · doi:10.3390/genes10110868 · Cited by 84
Pareja, F. G., Brown, D. N., Lee, J. Y., Paula, A. D. C., Selenica, P., Bi, R., Geyer, F. C., Gazzo, A. M., da Silva, E. M., Vahdatinia, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2563 · Cited by 79
Self-citationNascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
Wilkinson, S. C., Ye, H., Karzai, F. H., Harmon, S. A., Terrigino, N. T., VanderWeele, D. J., Bright, J. R., Atway, R., Trostel, S. Y., Carrabba, N. V., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.03.009 · Cited by 79
Sébert, M., Gachet, S., Leblanc, T. M., Rousseau, A., Bluteau, O., Kim, R., Abdelali, R. B., de Fontbrune, F. S., Maillard, L., Fédronie, C., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.01.006 · Cited by 81
Kanev, P.-B., Atemin, A., Stoynov, S., & Aleksandrov, R. (2023) · Seminars in Oncology · doi:10.1053/j.seminoncol.2023.08.001 · Cited by 89
Cancer Biomarker Discovery for Precision Medicine: New Progress
Zou, J., & Wang, E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180718164712 · Cited by 80
Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
Zhu, B., Xiao, Y., Yeager, M., Clifford, G. M., Wentzensen, N., Cullen, M., Boland, J. F., Bass, S. E., Steinberg, M. K., Raine‐Bennett, T. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14730-1 · Cited by 80
FANCM regulates repair pathway choice at stalled replication forks
Panday, A., Willis, N. A., Elango, R., Menghi, F., Duffey, E. E., Liu, E. T., & Scully, R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.044 · Cited by 75
Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma
Lee, J. J.-K., Louzada, S., An, Y., Kim, S. Y., Kim, S., Youk, J., Park, S., Koo, S. H., Keam, B., Jeon, Y. K., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw686 · Cited by 78
Self-citationIdentification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
Liu, J. C., Granieri, L., Shrestha, M., Wang, D., Vorobieva, I., Rubie, E. A., Jones, R. A., Ju, Y., Pellecchia, G., Jiang, Z., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.039 · Cited by 80
Self-citationKoedoot, E., Fokkelman, M., Rogkoti, V.-M., Smid, M., van de Sandt, I., de Bont, H., Pont, C., Klip, J. E., Wink, S., Timmermans, M. A. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11020-3 · Cited by 77
Self-citationBrinkman, A. B., Nik‐Zainal, S., Simmer, F., Rodríguez-González, F. G., Smid, M., Alexandrov, L. B., Butler, A. P., Martin, S., Davies, H. R., Głodzik, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09828-0 · Cited by 76
Self-citationModeling the process of human tumorigenesis
Balani, S., Nguyen, L. V., & Eaves, C. J. (2017) · Nature Communications · doi:10.1038/ncomms15422 · Cited by 80
Somatic evolution and global expansion of an ancient transmissible cancer lineage
Baez‐Ortega, A., Gori, K. C., Strakova, A., Allen, J. L., Allum, K. M., Bansse-Issa, L., Bhutia, T. N., Bisson, J. L., Briceño, C., Domracheva, A. C., et al. (2019) · Science · doi:10.1126/science.aau9923 · Cited by 80
Self-citationPellegrino, B., Musolino, A., Llop‐Guevara, A., Serra, V., Silva, P. D., Hlavata, Z., Sangiolo, D., Willard-Gallo, K. E., & Solinas, C. (2020) · Translational Oncology · doi:10.1016/j.tranon.2019.10.010 · Cited by 77
Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer
Sharma, U., Barwal, T. S., Malhotra, A., Pant, N., Vivek, Dey, D., Gautam, A., Tuli, H. S., Vásquez, K. M., & Jain, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118035 · Cited by 76
African-specific molecular taxonomy of prostate cancer
Jaratlerdsiri, W., Jiang, J., Gong, T., Patrick, S. M., Willet, C. E., Chew, T., Lyons, R. J., Haynes, A., Pasqualim, G., Louw, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05154-6 · Cited by 75
Self-citationUp-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer
Liu, Y., Du, Y., Hu, X., Zhao, L., & Xia, W. (2018) · BMC Cancer · doi:10.1186/s12885-018-4255-3 · Cited by 75
Gagliardi, A., Porter, V., Zong, Z., Bowlby, R., Titmuss, E., Namirembe, C., Griner, N. B., Petrello, H., Bowen, J., Chan, S. K., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0673-7 · Cited by 79
Dynamic roles of inflammasomes in inflammatory tumor microenvironment
Jang, J., Kim, D., & Surh, Y. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00154-7 · Cited by 79
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer
McCann, J. L., Cristini, A., Law, E. K., Lee, S. Y., Tellier, M., Carpenter, M. A., Beghè, C., Kim, J. J., Sanchez, A. R., Jarvis, M. C., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01504-w · Cited by 89
Self-citationLiu, H., Murphy, C. J., Karreth, F. A., Emdal, K. B., White, F. M., Elemento, O., Toker, A., Wulf, G. M., & Cantley, L. C. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0679 · Cited by 73
Bassani‐Sternberg, M., Digklia, A., Huber, F., Wagner, D., Sempoux, C. L., Stevenson, B. J., Thierry, A., Michaux, J., Pak, H., Racle, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01832 · Cited by 75
Aberrations in DNA repair pathways in cancer and therapeutic significances
Motegi, A., Masutani, M., Yoshioka, K., & Bessho, T. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.005 · Cited by 76
Ried, T., Meijer, G. A., Harrison, D. J., Grech, G., Franch‐Expósito, S., Briffa, R., Carvalho, B. G., & Camps, J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.007 · Cited by 74
New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
Han, Y., Yu, X., Li, S., Tian, Y. E., & Liu, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578095 · Cited by 73
Clinical utility of whole-genome sequencing in precision oncology
Rosenquist, R., Cuppen, E. P. J. G., Buettner, R., Caldas, C., Dreau, H. M.-P., Elemento, O., Frederix, G., Grimmond, S. M., Haferlach, T., Jobanputra, V., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.018 · Cited by 73
Self-citationNegrao, M. V., Raymond, V. M., Lanman, R. B., Robichaux, J. P., He, J., Nilsson, M. B., Ng, P. K., Amador, B. E., Roarty, E. B., Nagy, R. J., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.05.021 · Cited by 79
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL
Li, Z., Abraham, B. J., Berezovskaya, A., Farah, N., Liu, Y., León, T. E., Fielding, A. K., Tan, S. H., Sanda, T., Weintraub, A. S., et al. (2017) · Leukemia · doi:10.1038/leu.2017.75 · Cited by 73
Structural basis for adhesion G protein-coupled receptor Gpr126 function
Leon, K., Cunningham, R. L., Riback, J. A., Feldman, E., Li, J., Sosnick, T. R., Zhao, M., Monk, K. R., & Araç, D. (2020) · Nature Communications · doi:10.1038/s41467-019-14040-1 · Cited by 72
ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing
Eeckhoutte, A., Houy, A., Manié, É., Reverdy, M., Bièche, I., Marangoni, E., Goundiam, O., Vincent‐Salomon, A., Stoppa‐Lyonnet, D., Bidard, F., et al. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa261 · Cited by 72
Self-citationA glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Kong, L. R., Gupta, K., Wu, A., Perera, D., Iványi-Nagy, R., Ahmed, S. M., Tan, T. Z., Tan, S. L.-W., Fuddin, A., Sundaramoorthy, E., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.006 · Cited by 74
Trigos, A., Pearson, R. B., Papenfuss, A. T., & Goode, D. L. (2019) · eLife · doi:10.7554/elife.40947 · Cited by 72
Meghani, K. A., Fuchs, W., Detappe, A., Drané, P., Gogola, E., Rottenberg, S., Jonkers, J., Matulonis, U. A., Swisher, E. M., Konstantinopoulos, P. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.038 · Cited by 73
Self-citationAnnunziato, S., de Ruiter, J. R., Henneman, L., Brambillasca, C. S., Lutz, C., Vaillant, F., Ferrante, F., Drenth, A. P., van der Burg, E., Siteur, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08301-2 · Cited by 69
Self-citationAhmed, F., Ijaz, B., Ahmad, Z., Farooq, N., Sarwar, M. B., & Husnaın, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153168 · Cited by 73
Accelerated single cell seeding in relapsed multiple myeloma
Landau, H. J., Yellapantula, V. D., Diamond, B. T., Rustad, E. H., Maclachlan, K. H., Gundem, G., Medina-Martinez, J. S., Ossa, J. A., Levine, M. F., Zhou, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17459-z · Cited by 72
Update on prognostic and predictive biomarkers of breast cancer
Hou, Y., Peng, Y. S., & Li, Z. (2022) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2022.06.015 · Cited by 72
Bock, N., Forouz, F., Hipwood, L., Clegg, J., Jeffery, P. L., Gough, M., van Wyngaard, T., Pyke, C., Adams, M. N., Bray, L. J., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010261 · Cited by 73
APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential
Butler, K. E., & Banday, A. R. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01425-5 · Cited by 84
Heterogeneity Aware Random Forest for Drug Sensitivity Prediction
Rahman, R., Matlock, K., Ghosh, S., & Pal, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11665-4 · Cited by 71
PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
Zhao, Y., Montminy, T., Azad, T., Lightbody, E. D., Hao, Y., Sengupta, S., Asselin, É., Nicol, C. J. B., & Yang, X. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0593 · Cited by 72
Capsule Network Based Modeling of Multi-omics Data for Discovery of Breast Cancer-Related Genes
Chen, P., Zheng, Y., & Huang, D.-S. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2909905 · Cited by 70
Hodel, K. P., Sun, M. J. S., Ungerleider, N., Park, V. S., Williams, L. G., Bauer, D. L., Immethun, V. E., Wang, J., Suo, Z., Lu, H., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.012 · Cited by 70
Mechanisms of breast cancer metastasis
Nathanson, D. S., Detmar, M. J., Padera, T. P., Yates, L. R., Welch, D. R., Beadnell, T. C., Scheid, A. D., Wrenn, E. D., & Cheung, K. J. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10090-2 · Cited by 82
Self-citationBurns, A., Alsolami, R., Becq, J., Stamatopoulos, B., Timbs, A., Bruce, D. N., Robbe, P., Vavoulis, D. V., Clifford, R. M., Cabes, M., et al. (2017) · Leukemia · doi:10.1038/leu.2017.177 · Cited by 70
Zhang, G., Wang, Y., Chen, B., Guo, L., Cao, L., Ren, C., Wen, L., Li, K., Jia, M., Li, C., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.23 · Cited by 66
Germline Variants Impact Somatic Events during Tumorigenesis
Ramroop, J. R., Gerber, M. M., & Toland, A. E. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.005 · Cited by 68
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
Schade, A. E., Perurena, N., Yang, Y., Rodriguez, C. L., Krishnan, A., Gardner, A., Loi, P., Xu, Y., Nguyen, V. T. M., Mastellone, G. M., et al. (2024) · Nature · doi:10.1038/s41586-024-08031-6 · Cited by 72
van Schendel, R., van Heteren, J. V., Welten, R. D., & Tijsterman, M. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006368 · Cited by 65
Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
Coyle, K. M., Boudreau, J. E., & Marcato, P. (2017) · BioMed Research International · doi:10.1155/2017/9620870 · Cited by 72
APOBEC: From mutator to editor
Yang, B., Li, X., Lei, L., & Chen, J. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.04.009 · Cited by 70
Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
Buociková, V., Ríos-Mondragón, I., Pilalis, E. D., Chatziioannou, A. A., Miklikova, S., Mego, M., Pajuste, K., Ruciņš, M., Yamani, N. E., Longhin, E., et al. (2020) · Cancers · doi:10.3390/cancers12123622 · Cited by 69
Rodríguez‐Bautista, R., Ortega-Gómez, A., Hidalgo‐Miranda, A., Zentella‐Dehesa, A., Villarreal-Garza, C. M., Ávila‐Moreno, F., & Arrieta, O. G. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0514-z · Cited by 69
Lesurf, R., Griffith, O. L., Griffith, M., Hundal, J., Trani, L., Watson, M. A., Aft, R., Ellis, M. J., Ota, D., Suman, V. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx048 · Cited by 68
Baslan, T., Kendall, J., Volyanskyy, K. Y., McNamara, K. L., Cox, H., D'Italia, S., Ambrosio, F. J., Riggs, M. G., Rodgers, L., Leotta, A., et al. (2020) · eLife · doi:10.7554/elife.51480 · Cited by 67
Evolution of the mutation rate across primates
Chintalapati, M., & Moorjani, P. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.05.028 · Cited by 62
Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer
Knutsen, E., Harris, A. L., & Perander, M. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01588-3 · Cited by 70
Wilcox, N., Dumont, M., González‐Neira, A., Carvalho, S., Beauparlant, C. J., Crotti, M., Luccarini, C., Soucy, P., Dubois, S., Núñez‐Torres, R., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01466-z · Cited by 69
Self-citationMeijer, T. G., Verkaik, N. S., Sieuwerts, A. M., van Riet, J., Naipal, K. A. T., van Deurzen, C. H. M., den Bakker, M. A., Sleddens, H. F. B. M., Dubbink, H. J., den Toom, T. D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0063 · Cited by 71
Self-citationSingle-cell analysis based dissection of clonality in myelofibrosis
Mylonas, E., Yoshida, K., Frick, M., Hoyer, K., Christen, F., Kaeda, J., Obenaus, M., Noerenberg, D., Hennch, C., Chan, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13892-x · Cited by 72
Du, Z., Brown, B. P., Kim, S., Ferguson, D. C., Pavlick, D. C., Jayakumaran, G., Benayed, R., Gallant, J., Zhang, Y., Yan, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21613-6 · Cited by 68
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Seachrist, D. D., Anstine, L. J., & Keri, R. (2021) · Cancers · doi:10.3390/cancers13205205 · Cited by 68
Metadata
- Authors
- Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., Van Loo, P., Ju, Y. S., Smid, M., Brinkman, A. B., Morganella, S., Aure, M. R., Lingjærde, O. C., Langerød, A., Ringnér, M., Ahn, S.-M., Boyault, S., Brock, J. E., Broeks, A., Butler, A., Desmedt, C., Dirix, L., Dronov, S., Fatima, A., Foekens, J. A., Gerstung, M., Hooijer, G. K. J., Jang, S. J., Jones, D. R., Kim, H.-Y., King, T. A., Krishnamurthy, S., Lee, H. J., Lee, J.-Y., Li, Y., McLaren, S., Menzies, A., Mustonen, V., O’Meara, S., Pauporté, I., Pivot, X., Purdie, C. A., Raine, K., Ramakrishnan, K., Rodríguez-González, F. G., Romieu, G., Sieuwerts, A. M., Simpson, P. T., Shepherd, R., Stebbings, L., Stefansson, O. A., Teague, J., Tommasi, S., Treilleux, I., Van den Eynden, G. G., Vermeulen, P., Vincent-Salomon, A., Yates, L., Caldas, C., Veer, L. V., Tutt, A., Knappskog, S., Tan, B. K. T., Jonkers, J., Borg, Å., Ueno, N. T., Sotiriou, C., Viari, A., Futreal, P. A., Campbell, P. J., Span, P. N., Van Laere, S., Lakhani, S. R., Eyfjord, J. E., Thompson, A. M., Birney, E., Stunnenberg, H. G., van de Vijver, M. J., Martens, J. W. M., Børresen-Dale, A.-L., Richardson, A. L., Kong, G., Thomas, G., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Lund University (SE)
- Los Alamos National Laboratory (US)
- Erasmus MC (NL)
- Radboud University Nijmegen (NL)
- European Bioinformatics Institute (GB)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Gachon University Gil Medical Center (KR)
- Centre Léon Bérard (FR)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Université Libre de Bruxelles (BE)
- University of Antwerp (BE)
- Dana-Farber Cancer Institute (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Asan Medical Center (KR)
- Hanyang University (KR)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Institut National du Cancer (FR)
- Inserm (FR)
- Ninewells Hospital (GB)
- Institut Regional du Cancer de Montpellier (FR)
- The University of Queensland (AU)
- Istituto Tumori Bari (IT)
- University of Cambridge (GB)
- Institute of Cancer Research (GB)
- Haukeland University Hospital (NO)
- Singapore General Hospital (SG)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Radboud University Medical Center (NL)
- University of Iceland (IS)
- Corresponding author
- Viari, Alain
- Kong, Gu
- Stratton, Michael R.
- ORCID
- Davies, Helen
- Staaf, Johan
- Ramakrishna, Manasa
- Zou, Xueqing
- Alexandrov, Ludmil B.
- Martin, Sancha
- Wedge, David C.
- Ju, Young Seok
- Smid, Marcel
- Brinkman, Arie B.
- Morganella, Sandro
- Aure, Miriam R.
- Lingjærde, Ole Christian
- Ringnér, Markus
- Ahn, Sung-Min
- Boyault, Sandrine
- Brock, Jane E.
- Broeks, Annegien
- Desmedt, Christine
- Dirix, Luc
- Dronov, Serge
- Gerstung, Moritz
- Hooijer, Gerrit K. J.
- Jang, Se Jin
- Jones, David R.
- Krishnamurthy, Savitri
- Lee, Hee Jin
- Lee, Jeong-Yeon
- Li, Yilong
- McLaren, Stuart
- Menzies, Andrew
- Mustonen, Ville
- Pivot, Xavier
- Purdie, Colin A.
- Raine, Keiran
- Ramakrishnan, Kamna
- Rodríguez-González, F. Germán
- Sieuwerts, Anieta M.
- Simpson, Peter T.
- Shepherd, Rebecca
- Teague, Jon
- Tommasi, Stefania
- Treilleux, Isabelle
- Vermeulen, Peter
- Yates, Lucy
- Caldas, Carlos
- Veer, Laura van’t
- Tutt, Andrew
- Knappskog, Stian
- Tan, Benita Kiat Tee
- Jonkers, Jos
- Borg, Åke
- Ueno, Naoto T.
- Sotiriou, Christos
- Viari, Alain
- Futreal, P. Andrew
- Span, Paul N.
- Lakhani, Sunil R.
- Thompson, Alastair M.
- Birney, Ewan
- Stunnenberg, Hendrik G.
- Martens, John W. M.
- Richardson, Andrea L.
- Kong, Gu
- Thomas, Gilles
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2016-05-02
- Volume
- 534
- Issue
- 7605
- Pages
- 47-54
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4910866
- OpenAlex
- W2344657883
- Semantic Scholar
- abb27e35f11dcd60325f42f270b7811a4e852852
- Cited by
- 2,218
- References
- 60
- Citations by year
- 2026: 125 · 2025: 147 · 2024: 178 · 2023: 271 · 2022: 212 · 2021: 293 · 2020: 288 · 2019: 241 · 2018: 200 · 2017: 181 · 2016: 78
- FWCI
- 97.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-18)
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Energy (DE-AC52-06NA2-5396, AC52-06NA25396)
- Breast Cancer Research Foundation
- Dana-Farber/Harvard Cancer Center (P50 CA168504)
- University of Dundee
- Wellcome Trust (088177, 077012/Z/05/Z, 100183, 077012, WT100183MA, 098051)
- Francis Crick Institute (10202)
- QIMR Berghofer Medical Research Institute
- Cancer Research UK (60098573, 20952, CB4140, 16942)
- National Institute for Health and Care Research (NF-SI-0515-10090, NF-SI-0611-10154)
- Breast Cancer Campaign
- University of Cambridge
- European Commission (242006)
- National Research Foundation
- Icelandic Centre for Research
- Fonds De La Recherche Scientifique - FNRS
- Cancerfonden
- Cambridge University Hospitals (RG51913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Research Foundation of Korea (2015R1A2A1A10052578, 2011-0030105)
- Vetenskapsrådet
- Háskóli Íslands
- Institut National Du Cancer
- Rannís
- National Institutes of Health (DE-AC52-06NA25396)
- National Nuclear Security Administration (DEAC52- 06NA25396)
- National Cancer Institute (CA168504, P30CA008748, P50CA168504)
- Los Alamos National Laboratory (AC52-06NA25396, DE-AC52-06NA25396)
- FP7 Ideas: European Research Council (322737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- breast cancer, somatic mutations, driver mutations, mutational signatures, tandem duplication, homologous recombination deficiency, BRCA1, BRCA2, non-coding regions, intronic variants
- MeSH terms
- Breast Neoplasms, DNA Mutational Analysis, DNA Replication, DNA, Neoplasm, Female, Humans, Male, Mutation, Oncogenes, Cohort Studies, Genome, Human, Mutagenesis, Genes, BRCA1, Genomics, Genes, BRCA2, Mutation Rate, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
